• Biden's stimulus bill set to become law this week

    President Biden’s stimulus bill is set to become law this week after the Senate passed the amended bill on Saturday with only marginal changes.

  • Important signs of an improving outlook

    Stocks made record highs again last week and continue to benefit from better-than-expected corporate profits, lower COVID infection rates, an accelerating vaccine rollout, and the promise of additional fiscal stimulus from the Biden administration.

  • Encouraged by business surveys, vaccines, and corporate profits

    Improving business surveys, good news on lower infection rates, potential additional vaccine manufacturers, and better-than-expected corporate profitability support our positive outlook for 2021.

  • Volatility presents opportunity as vaccine rollout continues

    Market volatility increased last week with stocks having their worst week since October and finishing down for the month of January.

  • Housing and manufacturing remain strong, despite virus surge

    Housing and manufacturing conditions suggest a sustainable economic recovery remains in place, despite the surging virus and the impact it is having on consumer’s ability to spend.

  • Stimulus, vaccines, and pent-up demand bode well for 2021

    Stocks had their worst week since October last week, with the economic data showing the effects of renewed restrictions as the virus surge continues and as the effects of last spring’s massive CARES Act stimulus wanes.

  • Democratic control of Senate likely means more stimulus

    Stocks started the new year on an optimistic note with the S&P 500, Dow Jones Industrials, Nasdaq Composite, and the small-cap Russell 2000 all making record highs last week.

  • Stocks send optimistic signal for 2021

    Stocks finished 2020 on a positive note, looking past the continued spread of the virus and instead focusing on the positive news about vaccine development and distribution and the unprecedented monetary and fiscal stimulus.

  • Optimistic for 2021 with follow-on relief and Government funding in place

    Stocks are rising after President Trump signed the coronavirus relief and full-year government funding package into law.

  • Congress reaches deal on Coronavirus relief package

    With the virus still surging with associated economic headwinds, lawmakers have agreed to a roughly $900 billion follow-on COVID-19 relief package designed to further bridge the economy through this extraordinary period.

  • Market optimism remains high as vaccine rollout begins

    The rollout of Pfizer’s vaccine, which should be followed shortly by Moderna’s and others, is allowing the market and business leadership to focus on economic normalization as we move through 2021.

  • Stocks make new all-time highs looking past pandemic

    The Dow Jones Industrial Average, S&P 500, and Nasdaq Composite stock indexes all made record highs last week.

  • Vaccine candidates bring optimism that pandemic will fade

    Stocks continue to focus on a post-pandemic environment despite the high infection rate and new shutdowns that present near-term headwinds to economic activity.

  • Stocks are looking toward a brighter future

    While the number of COVID-19 cases continues to rise and remains a concern, the S&P 500 stock index gained 2.2% to an all-time high last week.

  • Georgia on our mind

    While President-elect Biden moves ahead with his transition plan to the White House, the January 5th Georgia Senate runoffs remain important for future policy developments.

  • Remaining optimistic independent of election outcome

    Stocks sold off last week as COVID-19 cases spiked in the U.S. and Europe, renewed lockdowns were announced across Europe, and uncertainty around the timing of stimulus and the election outcome continued.

  • We continue to see many positive economic developments

    While market concerns center on stimulus talks, election uncertainty, and rising COVID-19 cases, we remain encouraged by the incoming economic readings.

  • Economic recovery on track despite delays in stimulus

    Despite stalled stimulus talks and a stubbornly resilient virus, we remain optimistic on the outlook for stocks and other risk assets.

  • Economic growth is slowing but remains solid

    Stocks posted another healthy week of gains and the September market drawdown has mostly been erased over the past three weeks.

  • Consumer and business confidence continue to rebound

    While the President’s health, the upcoming election, and additional fiscal support are all presenting uncertainty for the market, the incoming economic data continues to support our positive recovery narrative.

For more information about Janney, please see Janney’s Relationship Summary (Form CRS) on www.janney.com/crs which details all material facts about the scope and terms of our relationship with you and any potential conflicts of interest.

To learn about the professional background, business practices, and conduct of FINRA member firms or their financial professionals, visit FINRA’s BrokerCheck website: http://brokercheck.finra.org/